Author: Chin Hui Leong

Singapore approved the Moderna (NASDAQ: MRNA) vaccine last week, marking another key milestone for the biotechnology company. But Moderna was not the only company that deserves some credit. The biotech firm had a huge helping hand from Veeva Systems (NASDAQ: VEEV), a software-as-a-service (SaaS) provider. As the pandemic spread around the world,...

If you haven’t heard of remdesivir, an antiviral drug, you will soon. Remdesivir is one of the most promising treatments for COVID-19 that is undergoing trial testing. In fact, shares of the drug’s maker, Gilead Sciences (NASDAQ: GILD), surged close to 10% on 17th April when initial...